Effect of Autogenic Relaxation Therapy on Caregivers on Perceived Stress Quality of Life and Caregiver Burden

NCT06687486 | Active Not Recruiting

• 1 other identifier: 2023/369
• Study Type: interventional
• Target: 64
• Locations: 1 country
• Sites: 1

Brief Summary

Caregivers are also faced with multiple stress factors. Autogenic relaxation therapy will help caregivers relax and take time for themselves by getting away from the stressful life they have lived. Although there are various studies on this subject (Chegeni et al. 2018, Seo and Kim 2019, Ramiraz-Garcia et al. 2020, Wang et al. 2021, Bagheri et all 2021, Ozhanlı and Akyuz 2022), there is no study on caregivers as far as we could reach. As a result of this study, nurses will help caregivers, whom they work one-on-one in most areas, to relax, thus helping to increase the quality of patient care in home environments and contributing to the increase in the quality of life of the caregiver. Thus, caregivers will be able to manage care more actively and effectively both at home and in clinics. Based on this purpose, the aim of the study is to reduce the anxiety level of caregivers, increase the quality of life and reduce the burden of care after autogenic relaxation therapy to be applied to caregivers.

Conditions

Caregiver Burnout; Caregiver; Care Burden

Outcome Measures

Primary Outcomes (1)

• Principial

  A decrease in the perceived stress scale score indicates a decrease in stress, an increase in the quality of life scale score indicates an increase in the quality of life, and a decrease in the care burden scale score indicates a decrease in the care burden. The secondary outcome measure is the decrease in the Perceived Stress Scale score, the increase in the Quality of Life Scale Score, and the decrease in the care burden scale score after autogenic relaxation therapy applied to caregivers.

  1 month

Secondary Outcomes (1)

• second

  3 month

Study Arms (2)

intervention

EXPERIMENTAL

Behavioral: relaxin

control

OTHER

Other: kontrol

Interventions

relaxin BEHAVIORAL

caregivers relaxing and care burden

intervention

kontrol OTHER

no intervention

control

Eligibility Criteria

• Age: 18 Years - 89 Years
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being over 18 years old
• Being able to answer data collection forms
• Being able to speak Turkish
• Being able to provide continuous or partial care to a patient for at least 3 months
• Being able to communicate

You may not qualify if:

• Having epilepsy
• Not speaking or understanding Turkish
• Having a neurological disability
• Having had an acute myocardial infarction
• Being diagnosed with schizophrenia and major depression
• Being addicted to alcohol or drugs
• Having a history of loss of consciousness

Sponsors & Collaborators

• Seda KARAKAYA ERGUN: lead

Study Sites (1)

Necmettin Erbakan Üniversitesi

Konya, 42450, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Caregiver Burden

Interventions

Relaxin

Condition Hierarchy (Ancestors)

Stress, Psychological; Behavioral Symptoms; Behavior

Intervention Hierarchy (Ancestors)

Corpus Luteum Hormones; Gonadal Hormones; Hormones; Hormones, Hormone Substitutes, and Hormone Antagonists; Peptide Hormones; Peptides; Amino Acids, Peptides, and Proteins

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Principal Investigator

Model Details: Individuals assigned as intervention and control will complete the research in these groups.

Study Record Dates

• First Submitted: November 7, 2024
• First Posted: November 13, 2024
• Study Start: November 7, 2024
• Primary Completion: November 30, 2024
• Study Completion: February 20, 2025
• Last Updated: November 13, 2024

Record last verified: 2024-06

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)